Media

With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Jul 10 2012
Washington, D.C. (July 10, 2012) – The Biotechnology Industry Organization (BIO) is expressing its strong support for bipartisan language contained in...
Jul 2 2012
The Biotechnology Industry Organization (BIO) today applauded the Department of Defense’s announced public-private partnership opportunity to support...
Jun 28 2012
  Pleased to move forward on biosimilars pathway Washington, D.C. (June 28, 2012) –Biotechnology Industry Organization (BIO) President...
Jun 27 2012
FDASIA headed to President for signature into law Washington, D.C. (June 26, 2012) –Biotechnology Industry Organization (BIO) President and...
Jun 21 2012
WASHINGTON, D.C. (Thursday, June 21, 2012) The 2012 BIO International Convention, the global event for biotechnology, wrapped up today at the Boston...
Jun 21 2012
WASHINGTON, D.C. (June 21, 2012) – The United States Senate overwhelmingly rejected an amendment today offered by Senator Bernie Sanders (I-VT) that...
Jun 21 2012
  Washington, D.C. (June 21, 2012) –Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following...
Jun 21 2012
Washington, D.C. (June 21, 2012) – The Biotechnology Industry Organization (BIO) released a report on the significant economic impact of...
Jun 20 2012
  Global Economics, International Advancements and Industry Reports Findings Impacting Sector Growth Hallmarked Day Two of 2012 BIO Convention...


Biotechnology News

March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...